?. Engstrom, T. Kelbaek, H. Helqvist, and S. , Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3???PRIMULTI): an open-label, randomised controlled trial, The Lancet, vol.386, issue.9994, pp.665-671, 2015.
DOI : 10.1016/S0140-6736(15)60648-1

?. Smits, P. Abdel-wahab, M. Neumann, and F. , Fractional Flow Reserve???Guided Multivessel Angioplasty in Myocardial Infarction, New England Journal of Medicine, vol.376, issue.13, pp.1234-1244, 2017.
DOI : 10.1056/NEJMoa1701067

?. Ibanez, B. James, S. Agewall, and S. , 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, European Heart Journal, vol.00, pp.1-66, 2017.
DOI : 10.1093/eurheartj/ehx393

D. ???katritsis, G. Siontis, and A. Kastrati, Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes, European Heart Journal, vol.32, issue.1, pp.32-40, 2011.
DOI : 10.1093/eurheartj/ehq276

?. Mehta, S. Granger, C. Boden, and W. , Early versus Delayed Invasive Intervention in Acute Coronary Syndromes, New England Journal of Medicine, vol.360, issue.21, pp.2165-2175, 2009.
DOI : 10.1056/NEJMoa0807986

?. Windecker, S. Kolh, P. Alfonso, and F. , 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Haert J, vol.35, issue.37, pp.2541-619, 2014.

L. ???jespersen, A. Hvelplund, and S. Abilstrøm, Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events, European Heart Journal, vol.33, issue.6, pp.734-744, 2012.
DOI : 10.1093/eurheartj/ehr331

?. Henderson, R. Pocock, S. Clayton, and T. , Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy, Journal of the American College of Cardiology, vol.42, issue.7, pp.1161-1170, 2003.
DOI : 10.1016/S0735-1097(03)00951-3

URL : https://doi.org/10.1016/s0735-1097(03)00951-3

?. Boden, W. O-'rourke, R. Teo, and K. , Optimal Medical Therapy with or without PCI for Stable Coronary Disease, New England Journal of Medicine, vol.356, issue.15, pp.1503-1516, 2007.
DOI : 10.1056/NEJMoa070829

URL : https://doi.org/10.1016/j.jvs.2007.04.027

?. Daly, C. , D. Stavola, B. Sendon, and J. , Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study, BMJ, vol.332, issue.7536, pp.262-267, 2006.
DOI : 10.1136/bmj.38695.605440.AE

S. ???-yusuf, D. Zucker, and P. Peduzzi, Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, The Lancet, vol.344, issue.8922, pp.563-570, 1994.
DOI : 10.1016/S0140-6736(94)91963-1

?. Dzavik, V. Ghali, W. Norris, and C. , Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators, American Heart Journal, vol.142, issue.1, pp.119-145, 2001.
DOI : 10.1067/mhj.2001.116072

?. Hachamovitch, R. Rozanski, A. Shaw, and L. , Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy, European Heart Journal, vol.32, issue.8, pp.1012-1024, 2011.
DOI : 10.1093/eurheartj/ehq500

B. ???-de-bruyne, N. Pijls, and B. Kalesan, Fractional Flow Reserve???Guided PCI versus Medical Therapy in Stable Coronary Disease, New England Journal of Medicine, vol.367, issue.11, pp.991-1001, 2012.
DOI : 10.1056/NEJMoa1205361

?. Velazquez, E. Lee, K. Deja, and M. , Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction, New England Journal of Medicine, vol.364, issue.17, pp.1607-1616, 2011.
DOI : 10.1056/NEJMoa1100356

E. ???velazquez, J. Williams, and E. Yow, Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy, The Annals of Thoracic Surgery, vol.93, issue.2, pp.523-530, 2012.
DOI : 10.1016/j.athoracsur.2011.10.064

?. Montalescot, G. Sechtem, U. Achenbach, and S. , 2013 ESC GUIDELINES ON THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE, Russian Journal of Cardiology, vol.34, issue.7, pp.2949-3003, 2013.
DOI : 10.15829/1560-4071-2014-7-7-79

P. ???shah, M. Durairaj, and I. Gordon, Factors affecting patency of internal thoracic artery graft: clinical and angiographic study in 1434 symptomatic patients operated between 1982 and 20021, European Journal of Cardio-Thoracic Surgery, vol.26, issue.1, pp.118-142, 2004.
DOI : 10.1016/j.ejcts.2004.02.037

?. Cameron, A. Davis, K. Grenn, G. Schaff, and H. , Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts ??? Effects on Survival over a 15-Year Period, New England Journal of Medicine, vol.334, issue.4, pp.216-225, 1996.
DOI : 10.1056/NEJM199601253340402

?. Loop, F. Lytle, B. Cosgrow, and D. , Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac Events, New England Journal of Medicine, vol.314, issue.1, pp.1-6, 1986.
DOI : 10.1056/NEJM198601023140101

?. Nordmann, A. Hengstler, P. Harr, T. Young, J. Bucher et al., Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials, The American Journal of Medicine, vol.116, issue.4, pp.253-262, 2004.
DOI : 10.1016/j.amjmed.2003.08.035

?. Stone, G. Witzenbichler, B. Guagliumi, and G. , Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial, The Lancet, vol.377, issue.9784, pp.2193-2204, 2011.
DOI : 10.1016/S0140-6736(11)60764-2

B. ????-kalesan, T. Pilgrim, and K. Heinimann, Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction, European Heart Journal, vol.33, issue.8, pp.977-987, 2012.
DOI : 10.1093/eurheartj/ehs036

?. Nakazawa, G. Finn, A. Vorpahl, M. Ladich, E. Kolodgie et al., Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents, Journal of the American College of Cardiology, vol.57, issue.4, pp.390-398, 2011.
DOI : 10.1016/j.jacc.2010.05.066

L. ????-raber, H. Kelbaek, and M. Ostojic, Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction, JAMA, vol.308, issue.8, pp.777-787, 2012.
DOI : 10.1001/jama.2012.10065

M. ????-sabate, A. Cequier, and A. Iniguez, Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial, The Lancet, vol.380, issue.9852, pp.1482-1490, 2012.
DOI : 10.1016/S0140-6736(12)61223-9

M. ????-sabate, S. Brugaletta, and A. Cequier, Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial, The Lancet, vol.387, issue.10016, pp.357-366, 2016.
DOI : 10.1016/S0140-6736(15)00548-6

?. Hofma, S. Brouwer, J. Velders, and M. , Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.60, issue.5, pp.381-387, 2012.
DOI : 10.1016/j.jacc.2012.01.073

URL : https://doi.org/10.1016/j.jacc.2012.01.073

?. Bonaa, K. Mannsverk, J. Wiseth, and R. , Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease, New England Journal of Medicine, vol.375, issue.13, pp.1242-1252, 2016.
DOI : 10.1056/NEJMoa1607991

S. ????-bangalore, S. Kumar, and M. Fusaro, Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials, BMJ, vol.345, issue.aug10 1, p.5170, 2012.
DOI : 10.1136/bmj.e5170

?. Tsai, T. Messenger, J. Brennan, and J. , Safety and Efficacy of Drug-Eluting Stents in Older Patients With Chronic Kidney Disease, Journal of the American College of Cardiology, vol.58, issue.18, pp.1859-1869, 2011.
DOI : 10.1016/j.jacc.2011.06.056

?. Kaiser, C. Galatius, S. Erne, and P. , Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries, New England Journal of Medicine, vol.363, issue.24, pp.2310-2319, 2010.
DOI : 10.1056/NEJMoa1009406

S. ????-bangalore, B. Toklu, and N. Amoroso, Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis, BMJ, vol.347, issue.nov08 1, p.6625, 2013.
DOI : 10.1136/bmj.f6625

?. Dangas, G. Serruys, P. Kereiakes, and D. , Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease, JACC: Cardiovascular Interventions, vol.6, issue.9, pp.914-922, 2013.
DOI : 10.1016/j.jcin.2013.05.005

?. Papakonstantinou, N. Baikoussis, N. Dedeilias, P. Argiriou, M. Charitos et al., Cardiac surgery or interventional cardiology? Why not both? Let's go hybrid, Journal of Cardiology, vol.69, issue.1, pp.46-56, 2017.
DOI : 10.1016/j.jjcc.2016.09.007

?. Mohr, F. Morice, M. Kappetein, and A. , Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial, The Lancet, vol.381, issue.9867, pp.629-667, 2013.
DOI : 10.1016/S0140-6736(13)60141-5

?. Park, S. Ahn, J. Kim, and Y. , Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease, New England Journal of Medicine, vol.372, issue.13, pp.1204-1216, 2015.
DOI : 10.1056/NEJMoa1415447

?. Mäkikallio, T. Holm, N. Lindsay, and M. , Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial, The Lancet, vol.388, issue.10061, pp.2743-52, 2016.
DOI : 10.1016/S0140-6736(16)32052-9

G. ????stone, J. Sabik, and P. Serruys, Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease, New England Journal of Medicine, vol.375, issue.23, pp.2223-2258, 2016.
DOI : 10.1056/NEJMoa1610227

?. Palmerini, T. Serruys, P. Kappetein, and A. , Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronay artery disease: A meta-analysis of 6 randomized trials and 4,686 patients The EXAMINATION trial (Everolimus- Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial, Am Haert J JACC Cardiovasc Interv. janv, vol.1907, issue.1, pp.54-6364, 2014.

K. ????thygesen, J. Alpert, and A. Jaffe, Third Universal Definition of Myocardial Infarction, Global Heart, vol.7, issue.4, pp.275-95, 2012.
DOI : 10.1016/j.gheart.2012.08.001

D. ????cutlip, S. Windecker, and R. Mehran, Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions, Circulation, vol.115, issue.17, pp.2344-51, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.685313

N. ????aissaoui, E. Puymirat, and X. Tabone, Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries ????Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock: Insights From the GUSTO-I Trial, Eur Heart J. oct J Am Coll Cardiol J Am Coll Cardiol. oct, vol.333650, issue.20318, pp.2535-431063, 2000.

M. ????sabatine, D. Morrow, and R. Giugliano, Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes, Circulation, vol.111, issue.16, pp.2042-2051, 2005.
DOI : 10.1161/01.CIR.0000162477.70955.5F

M. ????garfinkle, P. Lawler, K. Filion, M. Eisenberg, . Wc et al., Red blood cell transfusion and mortality among patients hospitalized for acute coronary syndromes: a systematic review Blood transfusion in elderly patients with acute myocardial infarction, N Engl J Med, vol.345, pp.1230-1236, 2001.

K. ????alexander, A. Chen, and T. Wang, Transfusion practice and outcomes in non???ST-segment elevation acute coronary syndromes, American Heart Journal, vol.155, issue.6, pp.1047-53, 2008.
DOI : 10.1016/j.ahj.2008.01.009

P. ????lawler, K. Filion, T. Dourian, R. Atallah, M. Garfinkle et al., Anemia and mortality in acute coronary syndromes: A systematic review and meta-analysis, American Heart Journal, vol.165, issue.2, pp.143-53, 2013.
DOI : 10.1016/j.ahj.2012.10.024

D. ????sudarsky, M. Sudarsky, S. Matezky, I. Goldenberg, A. Farcas et al., Impact of Early Invasive Approach on Outcomes of Patients With Acute Coronary Syndrome and Baseline Anemia: Analysis From the ACSIS Registry, Journal of Interventional Cardiology, vol.377, issue.9775, pp.315-340, 2015.
DOI : 10.1016/S0140-6736(11)60404-2

M. ????valgimigli, F. Costa, and Y. Lokhnygina, Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial, European Heart Journal, vol.38, issue.11, pp.804-810, 2017.
DOI : 10.1093/eurheartj/ehw525

G. ????ducrocq, P. Schulte, and A. Budaj, Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes, American Heart Journal, vol.186, pp.91-99, 2017.
DOI : 10.1016/j.ahj.2017.01.010

T. ????palmerini, B. Reggiani, L. , D. Riva, and D. , Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting, Journal of the American College of Cardiology, vol.69, issue.16, pp.2011-2022, 2017.
DOI : 10.1016/j.jacc.2017.02.029

L. ????van-der-heijden, M. Kok, and M. Löwik, Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial, EuroIntervention, vol.12, issue.17, pp.2128-2131, 2017.
DOI : 10.4244/EIJ-D-16-00571

J. ????iqbal, P. Serruys, and S. Silber, Comparison of zotarolimus-and everolimuseluting coronary stents: final 5-year report of the RESOLUTE all-comers trial Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database Duration of Dual Antiplatelet Therapy After Coronary Stenting. A review of the Evidence, Circ Cardiovasc Interv EuroIntervention J Am Coll Cardiol, vol.8766, issue.67, pp.1413-1419832, 2012.

D. ????sibbing, D. Aradi, and C. Jacobshagen, Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial, Lancet, issue.17, pp.140-673632155, 2017.

W. ????dewilde, T. Oirbans, and F. Verheugt, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, The Lancet, vol.381, issue.9872, pp.1107-1115, 2013.
DOI : 10.1016/S0140-6736(12)62177-1

C. ????gibson, R. Mehran, and C. Bode, Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI, New England Journal of Medicine, vol.375, issue.25, pp.2423-2434, 2016.
DOI : 10.1056/NEJMoa1611594

P. ????urban, I. Meredith, M. B. Abizaid, and A. , Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, N Engl J Med N Engl J Med, vol.373377, issue.12, pp.2038-471119, 2015.